Hepatitis Research Review, Issue 14

In this Issue:

High AST at LT predicts fibrosis risk post-LT?
Individual IFNs: specific roles in the immune response
Kinetic differences between IFN-α and IL28B in hepatocytes
Anti-HCV therapy improves renal, CV outcomes in diabetes
Boceprevir improves SVR in prior null-responders
Sleep disturbances in patients with HCV
TDF in lamivudine-resistant chronic HBV
SVR does not differ by age in HCV
Using FibroTest™ and FibroScan® to stage chronic HCV
Functional receptors identified for HBV and HDV

Please login below to download this issue (PDF)

Subscribe